Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Pasquier

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature Chemical Biology|October 20, 2014
A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagyBaptiste Ronan, Odile Flamand, Lionel Vescovi, et al.
Nature Communications|June 22, 2023
NBEAL2 deficiency in humans leads to low CTLA-4 expression in activated conventional T cellsLaure Delage, Francesco Carbone, Quentin Riller, et al.
Journal of Medicinal Chemistry|November 18, 2014
Discovery of (2S)-8-[(3R)-3-methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: a novel potent and selective inhibitor of Vps34 for the treatment of solid tumorsBenoit Pasquier, Youssef El-Ahmad, Bruno Filoche-Rommé, et al.
Autophagy|February 26, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)<sup>1</sup>Daniel J Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, et al.
Pageof 2